Publications by authors named "Pierluca Colacioppo"

Claim this Profile
I
Impact of chronic GLP-1 RA and SGLT-2I therapy on in-hospital outcome of diabetic patients with acute myocardial infarction.
Filippo Trombara, Nicola Cosentino, Alice Bonomi, Monica Ludergnani, Paolo Poggio, Pierluca Colacioppo

Cardiovasc Diabetol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diabetes mellitus duration and mortality in patients hospitalized with acute myocardial infarction.
Marta Baviera, Stefano Genovese, Pierluca Colacioppo, Nicola Cosentino, Andreana Foresta

Cardiovasc Diabetol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and safety of GLP-1 receptor agonists versus SGLT-2 inhibitors in type 2 diabetes: an Italian cohort study.
Marta Baviera, Andreana Foresta, Pierluca Colacioppo, Giulia Macaluso, Maria Carla Roncaglioni

Cardiovasc Diabetol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metformin use is associated with a decrease in the risk of hospitalization and mortality in COVID-19 patients with diabetes: A population-based study in Lombardy.
Luisa Ojeda-Fernández, Andreana Foresta, Giulia Macaluso, Pierluca Colacioppo, Mauro Tettamanti

Diabetes Obes Metab· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of oral anticoagulant drugs for arterial thromboembolism in patients with cancer.
Andreana Foresta, Pierluca Colacioppo, Marta Baviera, Luisa Ojeda-Fernandez, Claudio Cimminiello

Eur J Intern Med· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin treatment in patients with diabetes mellitus and heart failure in the era of new antidiabetic medications.
Lidia Staszewsky, Marta Baviera, Mauro Tettamanti, Pierluca Colacioppo, Fabio Robusto

BMJ Open Diabetes Res Care· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal trends from 2005 to 2018 in deaths and cardiovascular events in subjects with newly diagnosed rheumatoid arthritis.
Marta Baviera, Giovanni Cioffi, Pierluca Colacioppo, Mauro Tettamanti, Ida Fortino

Intern Emerg Med· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lower risk of death and cardiovascular events in patients with diabetes initiating glucagon-like peptide-1 receptor agonists or sodium-glucose cotransporter-2 inhibitors: A real-world study in two Italian cohorts.
Marta Baviera, Stefano Genovese, Vito Lepore, Pierluca Colacioppo, Fabio Robusto

Diabetes Obes Metab· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and safety of high and low dose NOACs in patients with atrial fibrillation.
Irene Marzona, Marco Proietti, Pierluca Colacioppo, Andreana Foresta, Marta Baviera

Eur J Intern Med· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of liver disease on oral anticoagulant prescription and major adverse events in patients with atrial fibrillation: analysis from a population-based cohort study.
Marco Proietti, Irene Marzona, Tommaso Vannini, Pierluca Colacioppo, Mauro Tettamanti

Eur Heart J Cardiovasc Pharmacother· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of venous thromboembolism in Northern Italy: A population-based study from 2013 to 2018.
Marta Baviera, Luca Barcella, Tommaso Vannini, Pierluca Colacioppo, Irene Marzona

Thromb Res· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis